Detalles de la búsqueda
1.
High-grade tumours promote growth of other less-malignant tumours in the same prostate.
J Pathol
; 253(4): 396-403, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33330991
2.
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data.
Eur Urol
; 81(3): 285-293, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980495
3.
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.
Am J Pathol
; 177(2): 1031-41, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20616342
4.
Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model.
BJU Int
; 107(11): 1818-24, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20860653
5.
Inhibitory effects of castration in an orthotopic model of androgen-independent prostate cancer can be mimicked and enhanced by angiogenesis inhibition.
Clin Cancer Res
; 12(24): 7431-6, 2006 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17189416
6.
Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
Cancer Res
; 64(16): 5664-71, 2004 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15313905
7.
Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype.
Neoplasia
; 18(3): 152-61, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26992916
8.
Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats.
Endocrinology
; 146(8): 3463-70, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15845622
9.
ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.
PLoS One
; 9(9): e105063, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25215939
10.
Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants.
PLoS One
; 8(11): e77407, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24244276
11.
Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Clin Cancer Res
; 16(4): 1245-55, 2010 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20145160
12.
Pigment epithelium-derived factor stimulates tumor macrophage recruitment and is downregulated by the prostate tumor microenvironment.
Neoplasia
; 12(4): 336-45, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20360944
13.
Hypoxia drives prostate tumour progression and impairs the effectiveness of therapy, but can also promote cell death and serve as a therapeutic target.
Expert Opin Ther Targets
; 13(2): 219-25, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19236239
14.
Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model.
Neoplasia
; 11(2): 177-86, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19177202
15.
Testosterone-stimulated growth of the rat prostate may be driven by tissue hypoxia and hypoxia-inducible factor-1alpha.
J Endocrinol
; 196(1): 11-9, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18180313
16.
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats.
Prostate
; 67(6): 573-81, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17252557
17.
A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Prostate
; 67(15): 1664-76, 2007 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17854058
18.
Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma.
BJU Int
; 98(3): 661-7, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16925769
19.
Neutralizing VEGF bioactivity with a soluble chimeric VEGF-receptor protein flt(1-3)IgG inhibits testosterone-stimulated prostate growth in castrated mice.
Prostate
; 58(1): 57-65, 2004 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14673953
20.
Localized expression of angiopoietin 1 and 2 may explain unique characteristics of the rat testicular microvasculature.
Biol Reprod
; 69(4): 1231-7, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12773423